Newsletter 18 November 2022
Full version: Web Aticeo
info@aticeo.com
#recycling #plastic #innovation
Trends
 

REAL-TIME HYPERSPECTRAL DATA TO RECYCLE

info@aticeo.com

For all its promise, the current state of solid-waste recycling leaves a lot to be desired. Plastic waste is among the worst: It represents about 12% of solid waste in the U.S., but only about 4.5% of what gets recycled.

 

Metaspectral thinks it has found a way to make the sorting problem easier, and it has raised a USD 4.7 Mln seed round to launch and expand its data analysis platform. They are not the first to try to crack plastics sorting, but they are taking a different tack than many, using hyperspectral imagery to decipher which plastic is which in real time.

 

Investors on the round include SOMA Capital, Acequia Capital and the Canadian government.

PE & VC Investments
#M&A
info@aticeo.com

Estée Lauder to acquire Tom Ford

 

The deal has totaled USD 2.8 Bln and is the largest in the luxury industry this year.

 

It comes as high-end brands are looking for new avenues for growth as business in China has become more difficult amid pandemic restrictions.

 

The acquisition was driven by the strength of Tom Ford’s beauty business but will also bring apparel to the firm.

 

 

 

 

 

#Startups
info@aticeo.com

Circularise brings circular economy to industrial supply chains

Netherlands-based Circularise, a software platform that provides end-to-end traceability for industrial supply chains, has announced an EUR 11 Mln funding round. 

 

Circularise says it will use the funds to advance its mission to bring a circular economy to supply chains, helping plastic manufacturers, brands, and OEMs to trace raw materials from the source into parts and, ultimately, to end products.

 

This investment was led by Brightlands Venture Partners.

#Fundraising
info@aticeo.com

Inveready launches a new biotech fund

 

Inveready, a spanish alternative asset manager, has come up with a new vehicle, Inveready Biotech IV, specialised in investing in companies in the biotechnology and life sciences sector, with a target size of EUR 50 Mln.

 

The vehicle will invest in approximately 20 companies and the contributions will be in the range of EUR 1 to 8 Mln per company and will be complemented by co-investment and/or public or private financing.

 
 
 
 
info@aticeo.com
Coming up
info@aticeo.com
LinkedIn
Website
Email
View this email in your browser
You are receiving this email because of your relationship with Aticeo Capital. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent to info@aticeo.com by info@aticeo.com
Vía Augusta, 2 bis, Barcelona, Catalonia, Spain


Unsubscribe from all mailings Unsubscribe | Manage Subscription | |


This is a Test Email only.
This message was sent for the sole purpose of testing a draft message.